Vulvar squamous cell carcinoma is the most common type of vulvar cancer, and it usually affects older adults, though younger people can also develop it. Early symptoms of vulvar squamous cell carcinoma can include ongoing itching, pain, burning, bleeding, or a sore, lump, or skin change on the vulva that does not go away. Many people only realize later that their symptoms were connected to vulvar squamous cell carcinoma. It can last for months before diagnosis, and the outlook depends on how far it has spread, with better survival when it is found early. Treatment often includes surgery, and some people also need radiation therapy or chemotherapy.
How many people live with Vulvar squamous cell carcinoma?
About 180,000 people worldwide were living with vulvar cancer diagnosed in the past 5 years (IARC GLOBOCAN, 2022); because about 85% to 90% of vulvar cancers are the squamous cell type (American Cancer Society, 2024), that suggests roughly 150,000 to 160,000 people worldwide are living with vulvar squamous cell carcinoma, although this is an estimate rather than a direct count. In the United States, about 24,000 people were living with vulvar cancer diagnosed in the past 5 years (IARC GLOBOCAN, 2022), which works out to an estimated 20,000 to 22,000 living with vulvar squamous cell carcinoma, again as an estimate rather than a direct count.
Overview
Vulvar squamous cell carcinomaSymptoms
Vulvar squamous cell carcinoma often causes ongoing itching, burning, pain, or tenderness of the vulva. Many also notice a lump, sore, thickened patch, or skin color change that does not go away. Spotting or bleeding can happen too.
Outlook and prognosis
The outlook for vulvar squamous cell carcinoma is often good when it is found early and treated promptly. Prognosis depends mainly on the tumor size, whether lymph nodes are involved, and whether the cancer has spread.
Causes and risk factors
Vulvar squamous cell carcinoma is linked to long-term human papillomavirus infection, smoking, and older age. Risk also rises with lichen sclerosus, a weakened immune system, prior cervical changes, and chronic vulvar irritation.
Genetic influences
Genetics matter in vulvar squamous cell carcinoma, but inherited causes are uncommon. Most genetic changes linked to vulvar squamous cell carcinoma happen in the tumor over time, often alongside HPV infection or long-term skin inflammation.
Diagnosis
Vulvar squamous cell carcinoma is usually diagnosed after a pelvic exam and a small tissue sample, called a biopsy. If cancer is confirmed, imaging may be used to check spread. Early diagnosis of vulvar squamous cell carcinoma can improve treatment planning.
Treatment and drugs
Treatment for vulvar squamous cell carcinoma often involves surgery to remove the cancer while preserving as much healthy tissue as possible. Some people also need radiation, chemotherapy, or both. Ongoing follow-up checks help watch for return and manage side effects.
Symptoms
Vulvar squamous cell carcinoma often first shows up as ongoing itching, irritation, pain, or a visible change in the skin of the vulva. Because the early symptoms of vulvar squamous cell carcinoma can look like a rash, yeast infection, or another skin problem, they are sometimes easy to dismiss. Symptoms vary from person to person and can change over time. A sore, lump, or patch that lasts for weeks deserves medical attention.
Persistent itching is one of the most common symptoms. It may feel stronger at night or keep coming back even after creams or treatments for irritation.
Some people notice soreness, stinging, burning, or tenderness in the vulvar area. Day to day, this can make sitting, walking, or wearing fitted underwear uncomfortable.
The skin may become thicker, rougher, raised, or change color. It can look white, red, pink, or darker than the surrounding skin instead of appearing smooth and even.
A new lump, wart-like growth, or firm area can appear on the vulva. It may be small at first but does not go away like a simple ingrown hair or minor irritation often does.
How people usually first notice Vulvar squamous cell carcinoma?
Many people first notice vulvar squamous cell carcinoma because of itching that does not go away, a sore or patch of skin that looks different, or a lump on the vulva that can feel tender, rough, or thicker than the surrounding skin. Some also notice burning, pain, bleeding not linked to a period, or a spot that changes color, especially if it keeps coming back instead of healing. These first warning signs of vulvar squamous cell carcinoma are often mistaken for common skin irritation or infection, so a change that lasts more than a few weeks is a good reason to see a clinician.
Types of Vulvar squamous cell carcinoma
Vulvar squamous cell carcinoma can show up in more than one form, and that can affect how it looks and feels day to day. Symptoms don’t always look the same for everyone. In practice, doctors often divide the main types of vulvar squamous cell carcinoma into an HPV-related form and an HPV-independent form. These variants of vulvar squamous cell carcinoma can cause similar symptoms, but they tend to differ in age group, skin changes, and how slowly they may develop.
HPV-related type
This type often affects younger or middle-aged adults and may appear as a wart-like growth, a sore area, or a patch that itches, burns, or bleeds. Some may notice a lump or a raw spot that does not heal, sometimes along with pain during sex or when urine touches the skin. It can develop from vulvar skin changes linked to human papillomavirus, so the area may look more visibly raised or uneven.
HPV-independent type
This type is more common in older adults and often develops in skin already affected by long-term irritation or conditions such as lichen sclerosus. Many living with vulvar squamous cell carcinoma of this type notice persistent itching first, followed by thickened skin, a tender crack, an ulcer, or a firm lump that slowly changes over time. Early symptoms of vulvar squamous cell carcinoma in this group can seem easy to dismiss because they may resemble chronic irritation rather than cancer.
Can I slow down the onset of symptoms?
Partly: there is no sure way to slow or stop vulvar squamous cell carcinoma from starting, but some well-supported steps can lower the risk, especially avoiding smoking, getting the HPV vaccine, and getting treatment for long-lasting vulvar itching, skin changes, or precancer found on an exam. These steps reduce risk rather than prevent cancer, and the evidence is much stronger for lowering the chance of cancer developing than for delaying symptoms once cancer has already begun. Regular checkups for ongoing vulvar symptoms can help find problems earlier and give more treatment options, which is worthwhile even though it cannot promise prevention.
What genetics can tell you about symptoms
For vulvar squamous cell carcinoma, genetics can sometimes help explain why the cancer develops and how it may behave, but they usually do not predict a specific set of day-to-day symptoms. Different genetic changes are seen in tumors linked to HPV infection versus those that arise without HPV, and these differences may affect how fast the cancer grows or how likely it is to come back, which can influence how severe symptoms become over time. Even so, symptoms such as itching, pain, bleeding, or a visible lump are more often shaped by the tumor’s size and location than by genetics alone.
Causes and risk factors
Most cases of vulvar squamous cell carcinoma are linked to long-lasting HPV infection, which is a common virus spread through sexual contact. Others start in vulvar skin changed by long-term inflammation, especially lichen sclerosus. It is rarely just one factor, and the mix matters. Older age, smoking, a weakened immune system, and past cervical or vaginal precancer are common risk factors for vulvar squamous cell carcinoma. Inherited risk is usually small, but rare genetic conditions that affect immunity or DNA repair can also increase risk.
What are the most common causes or risk factors?
The main risk factors for vulvar squamous cell carcinoma are getting older, long-term infection with certain types of HPV, a very common virus spread through sexual contact, smoking, and a weakened immune system. Risk is also higher in people living with long-lasting vulvar skin problems, especially lichen sclerosus, which can cause itching, fragile skin, and scarring, or in those who have had precancerous changes or other HPV-related cancers in the cervix, vagina, or anus. Unlike some cancers, this one is usually not linked to a strong inherited gene change, so family history is not a major risk factor for most people.
Environmental and biological risk factors
Vulvar squamous cell carcinoma is the most common type of vulvar cancer, and its risk tends to rise through a few well-known biological and environmental pathways. Doctors often group risks into internal (biological) and external (environmental). In practice, the main risk factors for vulvar squamous cell carcinoma include persistent human papillomavirus infection, older age, certain precancerous vulvar changes, and long-term inflammatory skin conditions.
Persistent infection with high-risk human papillomavirus, or HPV, is one of the strongest risk factors for vulvar squamous cell carcinoma. Over time, the virus can drive abnormal cell changes, especially when the infection does not clear on its own.
Risk rises with age, especially for the form of vulvar squamous cell carcinoma linked to long-standing skin disease rather than HPV. Many people are diagnosed after menopause, although it can occur earlier.
Precancerous changes in the vulva greatly increase the chance that vulvar squamous cell carcinoma can develop. This includes both HPV-related precancer and a less common type linked to chronic skin disease.
Lichen sclerosus is a long-term inflammatory skin condition of the vulva that can raise risk. Ongoing inflammation and repeated skin damage may make abnormal cell growth more likely.
Genetic risk factors
Vulvar squamous cell carcinoma is usually not passed down through families. Some risk factors are inherited through our genes. In most people, the key DNA changes arise in vulvar cells during life, and the pattern can differ between subtypes of vulvar squamous cell carcinoma. When people ask about the genetic risk factors for vulvar squamous cell carcinoma, the main point is that inherited causes are rare, while tumor gene changes are much more common.
No common gene: Most vulvar squamous cell carcinoma cases do not come from a single inherited gene change. In many people, the important DNA changes developed in the vulvar cells themselves rather than being passed down in a family.
Rare repair disorders: Rare inherited DNA repair disorders, especially Fanconi anemia, can raise the risk of squamous cell cancers, including cancers of the vulva. These conditions are uncommon, so they explain only a small share of vulvar squamous cell carcinoma cases.
TP53 changes: TP53 is a gene that normally helps damaged cells stop growing or die off. When TP53 is altered, abnormal cells can keep surviving and dividing. In most cases, this change is found in the tumor and is not present from birth.
CDKN2A loss: CDKN2A acts like a brake on cell growth. If that brake is lost, cells can divide more easily. This is usually a tumor change rather than an inherited one.
PIK3CA or HRAS: Changes in PIK3CA or HRAS can switch on growth signals that tell vulvar cells to keep multiplying. These mutations are usually not passed down through families, and they may be seen more often in some subtypes than others.
Lifestyle risk factors
Several everyday behaviors can influence the chance of developing vulvar squamous cell carcinoma, mainly by affecting HPV exposure, immune response, and chronic tissue irritation. Among the most important lifestyle risk factors for vulvar squamous cell carcinoma are smoking and sexual behaviors that raise the likelihood of persistent HPV infection. Other habits may not directly cause the cancer but can contribute to delayed detection or ongoing vulvar inflammation.
Tobacco use increases the risk of vulvar squamous cell carcinoma, especially in HPV-related disease. Smoking can weaken local immune defenses and make it harder for the body to clear high-risk HPV infection.
Having multiple sexual partners or unprotected sex can increase exposure to high-risk HPV types linked to vulvar squamous cell carcinoma. Persistent HPV infection is a major pathway for many vulvar cancers to develop over time.
Skipping routine gynecologic care can allow precancerous vulvar changes or persistent HPV-related disease to go unnoticed for longer. Earlier evaluation of itching, pain, skin color changes, or vulvar sores may help detect problems before they become more advanced.
Ongoing scratching, friction, or untreated vulvar symptoms may contribute to chronic inflammation in vulvar tissue. While irritation alone is not usually the main cause, long-standing inflammation can make abnormal areas harder to recognize and manage promptly.
Risk prevention
For many, prevention focuses on lowering the chance of vulvar squamous cell carcinoma by addressing a few well-known risks and catching changes early. The strongest proven steps are HPV vaccination, not smoking, and getting ongoing care for long-lasting vulvar skin conditions. Prevention is about lowering risk, not eliminating it completely.
HPV infection is a major cause of many cases of vulvar squamous cell carcinoma. Getting the HPV vaccine at the recommended age can greatly lower the risk, and some adults may still benefit depending on age and health history.
Smoking makes it harder for the body to clear HPV and raises the risk of vulvar squamous cell carcinoma. Quitting can help at any age, and support such as counseling or stop-smoking medicines often improves success.
Long-term vulvar skin problems, especially lichen sclerosus, can raise cancer risk if they are not treated and monitored. Using prescribed treatment and keeping follow-up visits can lower irritation and help spot dangerous changes early.
Pelvic and vulvar exams can help find precancer or cancer early, when treatment is often simpler and more effective. This matters even more if you have HPV, a history of abnormal cervical tests, or chronic vulvar itching, pain, or skin changes.
Can you prevent Vulvar squamous cell carcinoma?
You cannot fully prevent vulvar squamous cell carcinoma, but some cases may be lowered by reducing known risks. The most helpful steps are getting the HPV vaccine, not smoking, and getting medical care for ongoing vulvar itching, white patches, sores, or other long-lasting skin changes, because some of these changes can turn into cancer over time. Even with these steps, it can still happen, so early evaluation of new symptoms matters.
Transmission
Vulvar squamous cell carcinoma is not contagious, so it cannot be passed from one person to another through sex, touching, kissing, shared bathrooms, towels, or everyday close contact. If you are wondering whether vulvar squamous cell carcinoma is contagious, the answer is no.
Some cases are linked to long-term infection with certain types of human papillomavirus, or HPV, which can spread through sexual contact, but the virus is what spreads, not the cancer itself. Many living with vulvar squamous cell carcinoma did nothing to “give” it to someone else, and being around them does not put partners, family, or friends at risk.
When to test your genes
For vulvar squamous cell carcinoma, genetic testing is not usually used for early detection, because most cases are linked to HPV infection or chronic vulvar skin disease rather than an inherited cancer syndrome. Tumor testing may be considered in advanced, recurrent, or treatment-resistant cancer to help guide therapy.
Diagnosis
Vulvar squamous cell carcinoma is usually diagnosed after a new vulvar sore, lump, patch of skin change, itching, pain, or bleeding leads to a medical visit. Doctors usually begin with a careful exam of the vulva and nearby skin, because even small changes can matter. It’s natural to worry when symptoms don’t have a clear explanation. The diagnosis of vulvar squamous cell carcinoma is confirmed by testing a small tissue sample.
A clinician looks closely at the vulva, perineum, and nearby skin for ulcers, raised areas, color changes, or thickened patches. They may also examine the vagina, cervix, and anus to see whether there are signs of related disease or spread.
A small sample of tissue is removed from the abnormal area and examined under a microscope. This is the key test that confirms vulvar squamous cell carcinoma and helps rule out noncancerous skin conditions.
The lab checks the cancer type and how deeply it has grown into the tissue. This information helps guide staging and treatment planning.
Doctors feel the groin nodes during the exam because enlarged or firm nodes can suggest spread. Imaging tests may be added if the nodes seem abnormal or if the cancer appears more advanced.
How is Vulvar squamous cell carcinoma diagnosed?
Vulvar squamous cell carcinoma is usually diagnosed after a doctor examines the vulva and takes a small tissue sample, called a biopsy, from any sore, lump, itchy patch, or area that has changed or is not healing. The biopsy is the main test, because looking at the cells under a microscope is what confirms whether cancer is present. If cancer is found, scans and sometimes tests of the lymph nodes in the groin may be done to see if it has spread and to help plan treatment.
Stages of Vulvar squamous cell carcinoma
Vulvar squamous cell carcinoma is usually described by stage, which tells you how far the cancer has grown and whether it has spread. For many, the first step comes when usual activities start to feel different, such as ongoing itching, soreness, bleeding, or a lump that does not go away. Doctors work out the stage using the exam findings, a biopsy, imaging tests, and sometimes surgery, and this is also when early symptoms of vulvar squamous cell carcinoma are reviewed in context.
Stage 1
The cancer is only in the vulva or perineum, the area between the vaginal opening and anus. It has not spread to nearby lymph nodes or other parts of the body.
Stage 2
The cancer has grown into nearby structures such as the lower part of the urethra, lower vagina, or anus. It still has not spread to nearby lymph nodes or distant organs.
Stage 3
The cancer may be any size and has spread to nearby groin lymph nodes. This stage can vary depending on how many nodes are involved and how much cancer is found in them.
Stage 4A
The cancer has grown into nearby organs more extensively, such as the upper urethra, upper vagina, bladder lining, rectal lining, or pelvic bone, or it has heavily involved nearby lymph nodes. At this stage, treatment is often more complex and may combine surgery, radiation, and chemotherapy.
Stage 4B
The cancer has spread to distant parts of the body, such as the lungs, liver, or distant lymph nodes. Identifying the cause is the starting point for the right care, and staging helps the team plan the best support and treatment.
Outlook and prognosis
The outlook for vulvar squamous cell carcinoma depends mainly on stage at diagnosis, lymph node involvement, tumor size, and whether the cancer can be completely removed. When found early and confined to the vulva, treatment is often effective and long-term survival is generally favorable, with 5-year survival commonly exceeding 70% to 85%. Prognosis worsens when cancer has spread to the groin lymph nodes or beyond, and advanced or recurrent disease carries a substantially higher risk of death. In broad terms, reported 5-year survival is often around 40% to 60% with regional nodal spread and much lower, often under 20%, with distant metastases. Older age, significant other health problems, and delays in diagnosis can also negatively affect outcomes. Careful follow-up after treatment is important because local recurrence can occur, but some recurrences can still be treated successfully if detected early.
Long-term effects
For many, the long-term effects of vulvar squamous cell carcinoma depend on how far the cancer had grown and which treatments were needed. Some people do well after treatment and return to daily routines, while others live with lasting changes in comfort, mobility, or sexual health. It’s important to remember that long-term doesn’t always mean progressive, but careful follow-up matters because this cancer can come back, sometimes years later.
Vulvar squamous cell carcinoma can return in the vulva, nearby lymph nodes, or other parts of the body after treatment. This risk is usually highest in the first few years, but some may need long-term checks because recurrence can happen later as well.
Surgery or radiation can leave the vulvar area feeling tight, tender, numb, or different in shape and appearance. For many, this can mean discomfort with sitting, walking, cycling, or wearing close-fitting clothes.
Intimacy may feel different after vulvar squamous cell carcinoma because of pain, dryness, scarring, or reduced sensation. Some may also notice worry about touch, body image, or fear that sex will hurt, which can affect relationships over time.
If lymph nodes are removed or treated with radiation, fluid can build up and cause swelling in the groin, vulva, or legs. This is called lymphedema, and it can feel heavy, uncomfortable, and sometimes make movement harder.
How is it to live with Vulvar squamous cell carcinoma?
Living with vulvar squamous cell carcinoma can affect some of the most private parts of daily life, so the impact is often physical and deeply emotional at the same time. Many people living with this cancer deal with pain, itching, skin changes, tenderness, fatigue, and the stress of exams, surgery, radiation, or other treatment, which can make walking, sitting, exercise, work, sleep, urination, and sexual intimacy harder for a time or sometimes longer. It can also affect partners, family, and caregivers, who may take on practical help and emotional support, but with good cancer care, pain and symptom management, and honest communication, many find ways to protect comfort, relationships, and a sense of control.
Treatment and drugs
Vulvar squamous cell carcinoma is usually treated with a mix of surgery, and sometimes radiation therapy or drug treatment, depending on the size of the cancer, how deep it has grown, and whether it has spread to nearby lymph nodes. For many, this can mean an operation to remove the tumor while trying to preserve as much healthy tissue as possible, followed by recovery that can affect walking, sitting, urination, and sexual comfort for a while. Doctors sometimes recommend a combination of lifestyle changes and drugs when chemotherapy is used, often together with radiation, especially for more advanced disease or when surgery alone is not the best option. Some may also receive medicines that help with pain, skin irritation, infection risk, or nausea during treatment. Not every treatment works the same way for every person, so care is usually tailored by a cancer team based on the stage of vulvar squamous cell carcinoma, overall health, and personal priorities.
Can you cure Vulvar squamous cell carcinoma?
Vulvar squamous cell carcinoma, a common type of vulvar cancer, can often be cured if it is found early and treated, but there is not a guaranteed cure for every person. Treatment usually aims to remove or destroy the cancer, and it may also help control the disease, ease symptoms, and lower the chance of it coming back.
Non-drug treatment
Treatment often centers on removing or controlling the cancer while protecting comfort, mobility, and sexual function as much as possible. In vulvar squamous cell carcinoma, the main non-drug treatments are surgery and radiation, with other supportive therapies added based on symptoms and recovery needs. Managing this condition often means balancing cancer control with day-to-day concerns, such as sitting comfortably, using the bathroom, and healing after treatment. The best treatment for vulvar squamous cell carcinoma depends on the tumor size, where it sits on the vulva, whether lymph nodes are involved, and your overall health.
Surgery is the most common non-drug treatment and may remove only the tumor or a larger area of vulvar tissue. If there is concern that the cancer has spread, nearby groin lymph nodes may also be checked or removed. In many cases, surgeons aim to clear the cancer while preserving as much normal tissue as safely possible.
Radiation uses high-energy beams to destroy cancer cells and may be used instead of surgery or after surgery to lower the chance of the cancer coming back. Some people receive it for larger tumors, lymph node involvement, or when an operation would be too extensive. You might notice skin soreness, fatigue, or irritation in the treated area during the course of treatment.
Sometimes surgery and radiation are planned together to improve cancer control while limiting how much tissue needs to be removed. Not every approach works the same way, so the order and mix of treatments can differ from one person to another. A cancer team usually tailors this plan to the stage of vulvar squamous cell carcinoma and where the tumor is located.
Treatment often includes careful assessment of the groin lymph nodes because this helps guide the next steps and outlook. This may involve sentinel node mapping, which checks the first node or nodes most likely to collect cancer cells, or a fuller node removal when risk is higher. These procedures can affect healing and swelling, so follow-up care is important.
Your genes may have an impact on how drugs work for you
Small inherited differences in your genes can sometimes change how your body handles cancer medicines, which may affect how well a treatment works or how likely it is to cause side effects like severe nausea, low blood counts, or nerve pain. For people with vulvar squamous cell carcinoma, this kind of gene-based drug matching is not yet a routine part of care for most commonly used treatments, and doctors still mainly choose treatment based on the cancer’s size, spread, and your overall health. In some advanced cases, testing the tumor itself may help guide treatment choices, but inherited gene testing for medication response is not a standard part of care for most people living with this cancer.
Pharmacological treatments
Drug treatment for vulvar squamous cell carcinoma is most often used when the cancer is advanced, has come back, has spread, or is being treated together with radiation. Not everyone responds to the same medication in the same way. For many, treatment is chosen based on how far the cancer has spread, overall health, and whether tumor testing shows markers that make immunotherapy more likely to help.
Cisplatin is one of the most commonly used chemotherapy drugs for vulvar squamous cell carcinoma, especially when given with radiation to help the treatment work better in the same area. It may also be used for some people with recurrent or metastatic disease, although side effects such as nausea, kidney strain, hearing changes, and numbness can limit use.
Carboplatin and paclitaxel are often used together as treatment for advanced vulvar squamous cell carcinoma, especially when the disease has spread or surgery is not possible. This combination can help slow cancer growth, but it may cause fatigue, low blood counts, hair loss, and tingling in the hands or feet.
Paclitaxel may sometimes be used by itself if combination chemotherapy is not the best fit because of side effects or other health problems. Many living with vulvar squamous cell carcinoma may receive it to help control symptoms and disease growth rather than to cure the cancer.
Fluorouracil, also called 5-FU, is an older chemotherapy drug that may be used in some treatment plans, often alongside radiation rather than on its own. It is used less often than platinum-based treatment, but it can still be part of care in selected cases.
Genetic influences
For most people with vulvar squamous cell carcinoma, the cancer is not passed down in a simple inherited way. Instead, it usually develops after DNA changes build up in vulvar cells over time, often linked to long-term human papillomavirus (HPV) infection or, in other cases, chronic vulvar skin disease such as lichen sclerosus. Many people ask whether vulvar squamous cell carcinoma is hereditary, and the answer is usually no, although rare inherited conditions that affect DNA repair or immune function can raise risk.
Family history is one of the strongest clues to a genetic influence, but a family history of vulvar cancer alone is often less helpful than seeing a broader pattern of related cancers or cancers diagnosed at unusually young ages. Researchers have found gene changes inside vulvar squamous cell carcinoma tumors, especially in genes that help control how cells grow and repair themselves, but these changes are usually acquired during life rather than inherited from a parent. If several close relatives have had vulvar cancer or other cancers at younger ages, genetic counseling may help clarify whether there is a rare inherited risk and what screening makes sense for your family.
Is Vulvar squamous cell carcinoma genetic?
Genetics matter in vulvar squamous cell carcinoma, but inherited causes are uncommon. Most genetic changes linked to vulvar squamous cell carcinoma happen in the tumor over time, often alongside HPV infection or long-term skin inflammation.
Having a genetic risk is not necessarily a diagnosis
Changes in genes are a normal part of human biology and are common across the general population. Most of these variants do not directly affect health and are simply part of natural human diversity. For many genes, having a variant tied to a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental factors play a role. In some situations, though, one well-understood variant in a particular gene is enough to confirm a diagnosis.
Pharmacogenetics—how genetics influence drug effects
For many living with vulvar squamous cell carcinoma, treatment decisions are guided mostly by where the cancer is, how far it has spread, and overall health, rather than by inherited genes alone. In some cases, especially if vulvar squamous cell carcinoma comes back or has spread, doctors may test the tumor itself for certain DNA changes or immune markers that can help show whether targeted treatment or immunotherapy is worth considering. Beyond trial and error, genetics offers another way to match treatment more closely to the cancer, although this is still less established for vulvar cancer than for some other cancers. HPV-related tumors and tumors linked to other gene changes can behave differently, which may influence which medicines are discussed and how treatment is planned. Inherited genetic differences can also affect how strongly someone reacts to chemotherapy or how quickly the body clears some drugs, but this kind of pharmacogenetic testing is not yet routine in vulvar squamous cell carcinoma. If you are asking about genetic testing for vulvar squamous cell carcinoma treatment, it is usually most helpful in advanced or recurrent disease and is best discussed with your cancer team.
Interactions with other conditions
Living with vulvar squamous cell carcinoma can be more complicated when other health conditions are also part of the picture, because symptoms such as pain, itching, skin changes, or trouble sitting and walking may be harder to sort out. Another important aspect is how it may link with other diseases. This cancer can occur alongside long-term vulvar skin conditions, especially lichen sclerosus, and some cases are related to human papillomavirus, which also raises the risk of cancers of the cervix, vagina, or anus. People with weakened immune systems, including some living with HIV or taking immune-suppressing medicines, may have a higher chance of developing vulvar squamous cell carcinoma and may need closer follow-up. Other illnesses such as diabetes, poor circulation, or heart and lung disease do not usually cause the cancer, but they can affect surgery, wound healing, radiation tolerance, and overall recovery. If you are dealing with early symptoms of vulvar squamous cell carcinoma and already have another gynecologic, skin, or immune-related condition, it is especially important that your care team looks at the full picture rather than each problem on its own.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Vulvar squamous cell carcinoma?
Similar symptoms can happen with common problems such as yeast infections, eczema or psoriasis, long-term skin irritation of the vulva such as lichen sclerosus, genital warts or herpes, and a blocked gland that causes a painful lump near the vaginal opening. Pre-cancer changes in the vulvar skin can also look similar, which is why itching, pain, bleeding, or a sore that does not heal should be checked.
History
Changes in the skin of the vulva can be easy to dismiss at first. A sore that does not heal, itching that keeps coming back, or a patch of skin that slowly thickens may seem like a skin problem rather than cancer. For many living with vulvar squamous cell carcinoma, the story often begins with symptoms like these, sometimes lasting months before the cause becomes clear.
Doctors have recognized cancers of the vulva for a long time, but early descriptions were limited because there was little understanding of how different vulvar diseases differed from one another. In recent decades, awareness has grown, and vulvar squamous cell carcinoma is now understood as the most common type of vulvar cancer rather than a single vague category of “vulvar growth.” As pathology improved in the 19th and 20th centuries, doctors became better at examining tissue under a microscope and separating this cancer from infections, benign skin changes, and other less common vulvar tumors.
Treatment history also reflects how care has changed. Earlier surgery was often very extensive and could greatly affect walking, sitting, urination, sexual function, and day-to-day comfort. Over time, doctors learned that many people could be treated just as effectively with more tailored surgery, often combined with careful lymph node assessment and, in some cases, radiation or chemotherapy. This shift mattered because it aimed not only to control the cancer but also to reduce long-term effects on quality of life.
Researchers later recognized that vulvar squamous cell carcinoma can develop along more than one pathway. Some cases are linked to long-term infection with certain types of human papillomavirus, while others are more often associated with chronic vulvar skin conditions and tend to occur later in life. That better understanding helped explain why early symptoms of vulvar squamous cell carcinoma can look different from one person to another and why follow-up, biopsy, and treatment plans may vary.
Today, the history of vulvar squamous cell carcinoma is shaped by earlier diagnosis, more precise pathology, and more individualized treatment. Awareness has improved, although delays still happen because people may feel embarrassed, assume symptoms are minor, or not realize that persistent vulvar changes should be checked. Knowing this history helps explain why modern care places so much emphasis on noticing lasting symptoms early and choosing treatment that balances cancer control with everyday well-being.